DiaMedica's DM199 shows promise for Acute Ischemic Stroke, but caution is advised due to low market cap and trial outcome uncertainties. See more on DMAC here.
An avalanche of lawsuits filed against Bayer in Missouri is pitting the chemical maker against trial attorneys and cancer patients.
Prior to the Monday afternoon commemoration event, a group of WJC steering committee members, leading Jewish communal ...
The herbicide maker has settled or been ordered to pay out billions tied to lawsuits claiming the weedkiller Roundup causes ...
She is the co-founder of PowerZone Trading, a company that has provided programming, consulting, and strategy development services to active traders and investors since 2004. Diane Costagliola is ...
Financial terms of the deal were not disclosed.
Bayer BAYN-0.85%decrease; red down pointing triangle said the Federal Court of Australia closed the last pending case in the country over whether its Roundup weedkiller causes cancer, a win for ...
In the United States, Bayer will continue its multipronged strategy to significantly contain the Roundup™ litigation. Having achieved favorable outcomes in 15 of the last 22 trials, the company ...
Indeed, Bayer's latest earnings report highlighted to inventors that the company's struggles (beyond the litigation) will extend far into 2025. Notably, the company warned that 2025 will be weaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback